Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanoma

J Clin Oncol. 2007 Oct 1;25(28):4493-4. doi: 10.1200/JCO.2007.12.9338.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Leukemia, Myeloid / chemically induced*
  • Leukemia, Myeloid / pathology
  • Male
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Melanoma / secondary*
  • Middle Aged
  • Nitrosourea Compounds / adverse effects
  • Nitrosourea Compounds / therapeutic use*
  • Organophosphorus Compounds / adverse effects
  • Organophosphorus Compounds / therapeutic use*
  • Survival Analysis
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • fotemustine